Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens

European Journal of Pharmacology

Volumn 448, Issue 2-3, 2002, Pages 105-111

  Onali, Pierluigi ^a   Olianas, Maria C ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

cAMP; Dopamine D1 like receptor; Muscarinic receptor subtype; Nucleus accumbens

Indexed keywords

3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 FLUOROHEXAHYDROSILADIFENIDOL; 6 CHLORO 7,8 DIHYDROXY 3 ALLYL 1 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BENZAZEPINE DERIVATIVE; CARBACHOL; DIFENIDOL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; MUSCARINIC TOXIN 3; MUSCARINIC TOXIN 7; OTENZEPAD; PIRENZEPINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; CYCLIC AMP; MUSCARINIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING ASSAY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; MALE; MEMBRANE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCARINIC ANTAGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M4; RECEPTORS, DOPAMINE D1; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 0037135020     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01910-6     Document Type: Article

References (38)

1. Muscarinic receptor subtype selective toxins
2. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
4. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat
5. Interaction between glutamatergic and mono-aminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
6. Muscarinic receptors: Characterization, coupling and function
7. International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors
8. 50) of an enzymatic reaction
9. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390
10. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell
11. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats
12. 1 receptors
13. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice
14. The neurobiology of slow synaptic transmission
15. Convergence and segregation of ventral inputs and outputs
16. Accumbens cholinergic interneurons play a role in the regulation of body weight and metabolism
17. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens
18. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
19. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices
20. Molecular characteristics of mammalian dopamine receptors
21. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies
22. Regulation of neurotransmitter interactions in the ventral striatum
23. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement
24. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems
25. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum
26. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: Potent block by the selective m4 ligand muscarinic toxin 3 (MT3)
27. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex
28. 1 receptors in cerebral cortex and neostriatum: Evidence for heterogeneity in affinity states and cortical distribution
29. Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
30. A highly sensitive adenylate cyclase assay
31. Pharmacological characterization of PD102807: An m4 selective muscarinic antagonist
32. Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover
33. Adrenoceptors and their second messenger systems
34. 1
35. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum
36. 2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy